1 / 4

Global Enzyme Replacement Therapy Market Size, Industry Trends, Share and Forecast 2019-2025

The global enzyme replacement therapy market is anticipated to grow at a significant CAGR during the forecast period. The enzyme replacement therapy is a favorable solution to the people diagnosed with a rarer disease such as Hunter syndrome, Fabery disease, Pompe disease, and many more.

mansi3210
Download Presentation

Global Enzyme Replacement Therapy Market Size, Industry Trends, Share and Forecast 2019-2025

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Orion Market Research Global Enzyme Replacement Therapy Market, Size, Share, Analysis Report & Forecast to 2025 Request https://www.omrglobal.com/request-sample/enzyme-replacement-therapy-market a Free Sample of our Global Enzyme Replacement Therapy Market: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 780-304-0404

  2. Global enzyme replacement therapy market is anticipated to grow at a significant CAGR during the forecast period. The deficiency of certain enzymes results in the progressive accumulation of the deficient enzyme's substrate. Enzyme replacement therapy is one such treatment that is used in the rarer disease to correct the deficient enzyme level. This will drive the enzyme replacement market during the forecast period. Rarer diseases prevalence across the globe is common. According to the World Economic Forum in 2018, it is estimated that 350 million individuals are living with a rare disease. Hence, the huge patient number is anticipated to expand the enzyme replacement therapy market size. A https://www.omrglobal.com/industry-reports/enzyme-replacement-therapy-market full Report of Global Enzyme Replacement Therapy Market is Available at: Enzyme deficiencies can cause conditions of a rare disease such as Gaucher, Fabry's, and Hunter syndrome. Therefore, the raising cases of such rare disease will also fuel the enzyme replacement therapy industry. Enzyme replacement therapy uses only the human cells to cure the rare disease which minimizes the possibility of reaction and infection. This in turn will drive the adoption of enzyme therapy hence impacting the enzyme replacement therapy market growth. Additionally, most of the rare diseases are special and don’t have any ethical treatment solutions to it till now. Enzyme replacement therapy is the first enzyme targeted therapy to cure several of these rare diseases. Therefore, the adoption of the therapy is anticipated to increase significantly and drive the enzyme replacement therapy market during the forecast period. Request https://www.omrglobal.com/request-sample/enzyme-replacement-therapy-market a Free Sample of our Global Enzyme Replacement Therapy Market: Moreover, many companies are also investing in updating their enzyme replacement therapy product offerings by the addition of new drugs and therapies which will drive the enzyme replacement therapy market considerably. • In January 2020, Entrada Therapeutics, Inc. announced its engagement in the development of ENTR-501, which is a novel thymidine phosphorylase enzyme replacement therapy. It is indicated for the treatment of mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) that affects the digestive and nervous systems of the patient. In February 2020, Synspira Therapeutics announced an agreement with the Cystic Fibrosis Foundation to support the development of SNSP003. It is an orally delivered non-porcine enzyme replacement therapy by the Synspira that is designed to treat Malabsorption Syndromes. The development of SNSP003 could represent the first significant enzyme replacement therapy advancement. The SNSP003 enzyme replacement therapy possesses the potential to be the broad-spectrum non-porcine product that addresses malabsorption of fat, protein, and carbohydrates. • Global Enzyme Replacement Therapy Market – Segmentation By Enzyme Types • • Agalsidase Beta Agalsidase Alfa

  3. • • Galsulfase Others By Indication • • • • Fabry Disease Gaucher Disease Pompeo Disease Others Global Enzyme Replacement Therapy Market- Segment by Region North America • • US Canada Europe • • • • • • Germany UK France Spain Italy Rest of Europe Asia-Pacific • • • • China Japan India Rest of Asia-Pacific Rest of the World Company Profiles •AbbVie Inc. •Actelion Pharmaceuticals Ltd •Alexion Pharmaceuticals, Inc. •Amicus Therapeutics Inc. •Audentes Therapeutics Inc. •BioMarin Pharmaceutical Inc •Entrada Therapeutics, Inc. •Horizon Therapeutics plc

  4. •Leadiant Biosciences, Inc. •Merck KGaA •Pfizer Inc. •Pharming Group NV •Protalix BioTherapeutics Inc. •Recordati S.p.A. •Sanofi S.A. •Synspira Therapeutics Inc. •Takeda Pharmaceutical Co. Ltd. •TEIJIN Ltd. For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report- customization/enzyme-replacement-therapy-market About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research- based services. For More Information, Visit Orion Market Research Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 7803040404

More Related